113 related articles for article (PubMed ID: 23174854)
1. Low concentration of arsenic-induced aberrant mitosis in keratinocytes through E2F1 transcriptionally regulated Aurora-A.
Wu CH; Tseng YS; Kao YT; Sheu HM; Liu HS
Toxicol Sci; 2013 Mar; 132(1):43-52. PubMed ID: 23174854
[TBL] [Abstract][Full Text] [Related]
2. Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.
Kao YT; Wu CH; Wu SY; Lan SH; Liu HS; Tseng YS
BMC Cancer; 2017 Apr; 17(1):277. PubMed ID: 28420331
[TBL] [Abstract][Full Text] [Related]
3. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models.
Zhang D; Hirota T; Marumoto T; Shimizu M; Kunitoku N; Sasayama T; Arima Y; Feng L; Suzuki M; Takeya M; Saya H
Oncogene; 2004 Nov; 23(54):8720-30. PubMed ID: 15480417
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 subverts p63 control over KLF4 expression in keratinocytes.
Cordani N; Pozzi S; Martynova E; Fanoni D; Borrelli S; Alotto D; Castagnoli C; Berti E; ViganĂ² MA; Mantovani R
Oncogene; 2011 Feb; 30(8):922-32. PubMed ID: 20972454
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A overexpression in mouse liver causes p53-dependent premitotic arrest during liver regeneration.
Li CC; Chu HY; Yang CW; Chou CK; Tsai TF
Mol Cancer Res; 2009 May; 7(5):678-88. PubMed ID: 19435814
[TBL] [Abstract][Full Text] [Related]
6. TRF1 mediates mitotic abnormalities induced by Aurora-A overexpression.
Ohishi T; Hirota T; Tsuruo T; Seimiya H
Cancer Res; 2010 Mar; 70(5):2041-52. PubMed ID: 20160025
[TBL] [Abstract][Full Text] [Related]
7. Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.
Temme A; Geiger KD; Wiedemuth R; Conseur K; Pietsch T; Felsberg J; Reifenberger G; Tatsuka M; Hagel C; Westphal M; Berger H; Simon M; Weller M; Schackert G
J Neuropathol Exp Neurol; 2010 Jun; 69(6):632-42. PubMed ID: 20467329
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
9. Arsenic carcinogenesis in the skin.
Yu HS; Liao WT; Chai CY
J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of nuclear accumulated Aurora-A.
Tatsuka M; Sato S; Kanda A; Miki T; Kamata N; Kitajima S; Kudo Y; Takata T
Mol Carcinog; 2009 Sep; 48(9):810-20. PubMed ID: 19204928
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.
Wang X; Zhou YX; Qiao W; Tominaga Y; Ouchi M; Ouchi T; Deng CX
Oncogene; 2006 Nov; 25(54):7148-58. PubMed ID: 16715125
[TBL] [Abstract][Full Text] [Related]
12. Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer.
Tseng YS; Tzeng CC; Huang CY; Chen PH; Chiu AW; Hsu PY; Huang GC; Wang YC; Liu HS
Cancer Lett; 2006 Sep; 241(1):93-101. PubMed ID: 16338065
[TBL] [Abstract][Full Text] [Related]
13. Concentration-dependent cellular responses of arsenic in keratinocytes.
Liao WT; Lan CC; Lee CH; Yu HS
Kaohsiung J Med Sci; 2011 Sep; 27(9):390-5. PubMed ID: 21914526
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma.
Yang SB; Zhou XB; Zhu HX; Quan LP; Bai JF; He J; Gao YN; Cheng SJ; Xu NZ
Oncol Rep; 2007 May; 17(5):1083-8. PubMed ID: 17390048
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Lin YC; Sun SH; Wang FF
Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
[TBL] [Abstract][Full Text] [Related]
16. [The role of PPARbeta in the apoptotic HaCaT keratinocytes induced by TNF-alpha].
Liang PF; Jiang BM; Zhang PH; Yang XH; Long JH; Huang XY
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2144-8. PubMed ID: 17988538
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
19. Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity.
LeRoy PJ; Hunter JJ; Hoar KM; Burke KE; Shinde V; Ruan J; Bowman D; Galvin K; Ecsedy JA
Cancer Res; 2007 Jun; 67(11):5362-70. PubMed ID: 17545617
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-dependent regulation of the human aurora B promoter.
Kimura M; Uchida C; Takano Y; Kitagawa M; Okano Y
Biochem Biophys Res Commun; 2004 Apr; 316(3):930-6. PubMed ID: 15033491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
